Although prevention and treatment strategies are available for influenza, they are not sufficient for vulnerable populations such as young children and newborns. In a new study published in Virology, a multidisciplinary team ...
Mar 18, 2024
0
0
Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an increased risk for incident autoimmune inflammatory rheumatic disease (AIRD) compared with matched patients with influenza infection ...
Mar 5, 2024
0
1
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein ...
Mar 1, 2024
0
50
The 2023 to 2024 seasonal influenza vaccine is effective for reducing the risk for medically attended influenza virus infection, according to research published in the Feb. 29 issue of the U.S. Centers for Disease Control ...
Mar 1, 2024
0
5
U.S. flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says a University of Michigan researcher. Currently, all influenza vaccines in the United States are quadrivalent, ...
Feb 29, 2024
0
0
Children born in October are both more likely to be vaccinated against influenza and least likely to be diagnosed with influenza compared with children born in other months, finds a US study published by The BMJ.
Feb 21, 2024
0
23
Researchers have shed new light on how viral evolution, population immunity, and the co-circulation of other flu viruses shape seasonal flu epidemics.
Feb 13, 2024
0
33
Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral ...
Feb 6, 2024
0
48
Pregnant patients are more likely to accept COVID-19 vaccination if they receive other routine vaccines during pregnancy, according to a study published in the December issue of the Journal of Infection.
Jan 19, 2024
1
11
The latest studies at Hudson Institute of Medical Research have identified a novel therapy that controls the body's response to the influenza virus, limiting damaging inflammation and promoting recovery from severe infection.
Jan 16, 2024
0
0
